Friday 6 November 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue: +4.68%
EPS: −130.7%
Free cash flow: +77.0%
Total debt: +50.4%

Quarter to September 2026, against a year earlier

146.92 3.44 −2.29%

Follow MRK

Alert me

Market cap: $362.5B
P/E: 118×
Fwd P/E: 109×
Dividend yield: 2.31%
F-score: 4/9
Altman Z: 3.77
Beneish M: −2.27
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Merck & Co., Inc. (MRK) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Merck & Co., Inc. (MRK) trades at a P/E ratio of 118×. Over the past ten years it has ranged from 10.7× (May 2025) to 943× (March 2024); the current reading is higher than 94% of that period. That is above the Drug Manufacturers General industry median of 26.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MRK/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Merck &amp; Co., Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MRK/metrics/pe-ratio">Merck &amp; Co., Inc. (MRK) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	14.5×	(2.18%)
FY2024	14.8×	(98.17%)
FY2023	809×	4,070.18%
FY2022	19.4×	30.59%
FY2021	14.9×	(47.88%)
FY2020	28.5×	23.71%
FY2019	23.0×	(27.52%)
FY2018	31.8×	(45.52%)
FY2017	58.3×	40.64%
FY2016	41.5×	28.41%

Period	P/E ratio	Change
Sep 2026	116×	13.08%
Jun 2026	103×	203.38%
Mar 2026	33.9×	134.35%
Dec 2025	14.5×	30.41%
43 more quarters	Free account

Against its own ten years

Low 10.7× High 943×

Ten-year median 25.1×

Current reading's percentile 93

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
NVO Novo Nordisk A/S compare	9.9×
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG compare	30.9×
JNJ Johnson & Johnson compare	41.3×
PFE Pfizer Inc. compare	42.2×
ABBV AbbVie Inc. compare	49.7×
MRK Merck & Co., Inc.	118×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Merck & Co., Inc. (MRK) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on MRK

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on MRK

Stockrow Weekly